Events

Anne Walsh is speaking at FDLI’s Hybrid Event: Enforcement, Litigation, and Compliance Conference For the Drug, Device, Food, and Tobacco IndustriesDecember 7th, 2023
Dave Clissold is speaking at Global Cardio Vascular Clinical Trialists ForumDecember 2nd, 2023
Kurt Karst is speaking at ACI’s Summit on Life Sciences IP Due DiligenceNovember 29th, 2023
Webinar: Biosimilars and Interchangeable Biologics: New FDA Draft GuidanceNovember 28th, 2023
Lisa Baumhardt is speaking at Radiological Society of North America (RSNA) Annual Meeting – Best Practices for AI Model Regulation and Human-AI CollaborationNovember 27th, 2023
Ricardo Carvajal is speaking at American Herbal Products Association’s Regulatory CongressNovember 14th, 2023
Kurt Karst is speaking at APIIC Plenary Event: Pathway to Build Supply Chain Resilience to Critical DrugsNovember 8th, 2023
Sara Koblitz is speaking at Food and Drug Law Journal’s 2023 Symposium: Regulating on Shifting Sands: Analyzing the Impact of Recent and Upcoming Federal Court Decisions on FDA’s AuthorityNovember 8th, 2023
Anne Walsh is speaking at IBA Annual ConferenceOctober 29th, 2023
Sara Koblitz is speaking at ACI’s Paragraph IV Disputes Master SymposiumOctober 24th, 2023
John Gilbert is speaking at the 2023 National Association of State Controlled Substances Authorities (NASCSA) ConferenceOctober 24th, 2023
Allyson Mullen is speaking at AMDM’s 2023 IVD Hybrid Focus MeetingOctober 19th, 2023
John Claud is speaking at ACI’s Forum on Defending FDA-Regulated Consumer Products Class ActionsOctober 16th, 2023
Kurt Karst and Sara Koblitz are speaking at ACI’s Virtual Course: Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIAOctober 12th, 2023
Webinar: Clinical Trial Diversity: Understanding and Addressing the Implications of the Food and Drug Omnibus Reform Act of 2022 (“FDORA”);October 11th, 2023
Webinar: Recent Hospital Controlled Substances Diversion Cases – Cautionary TalesOctober 3rd, 2023
Kurt Karst and Sara Koblitz are speaking at GRx + Biosims 2023: Generics and Biosimilars ConferenceOctober 2nd, 2023
Riette van Laack is speaking at ACI’s Legal, Regulatory & Compliance Forum on Cosmetics & Personal Care ProductsSeptember 27th, 2023
Kurt Karst is speaking at ACI’s FDA Boot CampSeptember 20th, 2023
Ricardo Carvajal is speaking at CHPA Regulatory Scientific & Quality ConferenceSeptember 19th, 2023
Faraz Siddiqui is speaking at Medicaid Drug Rebate Program SummitSeptember 19th, 2023
Riette van Laack is speaking at ACC’s Nutrition Law SymposiumSeptember 8th, 2023
Larry Houck is speaking at the 2023 Opioid Abuse Management SummitJuly 20th, 2023
Riette van Laack is speaking at IFT FIRST Short Course: Labeling Requirements and Implications for Food Marketed in the U.S.July 15th, 2023
Ricardo Carvajal is speaking at ACI’s Legal, Regulatory & Compliance Forum on Dietary SupplementsJune 28th, 2023
Charles Raver is speaking at DIA 2023 Global Annual Meeting – ILLUMINATEJune 28th, 2023
James Valentine is speaking at DIA 2023 Global Annual Meeting – ILLUMINATEJune 28th, 2023
Anne Walsh is Co-Chair of the International Bar Association’s World Life Science ConferenceJune 1st, 2023
HPM Webinar: Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock InspectionsMay 24th, 2023
Anne Walsh is speaking at FDLI’s 2023 Annual ConferenceMay 17th, 2023
Sophia Gaulkin is speaking at Informa Connect’s Drug Pricing Transparency CongressMay 16th, 2023
Jeff Shapiro is speaking at the Florida Medical Device SymposiumMay 3rd, 2023
FDA News Webinar: Medical Device Enforcement: Are You Up-to-Date on the Latest DevelopmentsApril 20th, 2023
Kurt Karst is speaking at ACI’s Paragraph IV Disputes: Strategies for Brand Name and GenericsApril 19th, 2023
Riette Van Laack is speaking at ACI’s Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products ConferenceMarch 28th, 2023
Ricardo Carvajal is a moderator at FDLI’s Food and Dietary Supplement Safety and Regulation Conference (Virtual Event)March 24th, 2023
Larry Houck is speaking at American Pharmacists Annual MeetingMarch 24th, 2023
HPM Webinar: The “End” of the COVID-19 Emergency: the Ryan Haight Act, Telemedicine and Next StepsMarch 23rd, 2023
Kurt Karst is Co-Chair of FDA Bootcamp – Training in Core Regulatory Concepts for Life Sciences Attorneys, Business Executives, and Policy AnalystsMarch 22nd, 2023
Riette Van Laack is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 22nd, 2023
Ricardo Carvajal is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 21st, 2023
Doug Farquhar is speaking at Pharma Conference’s Current Hot GMP TopicsFebruary 8th, 2023
Frank Sasinowski will be panelist in Webinar: 2023 Wow! or Yeow!? FDA Outlook for 2023 and BeyondJanuary 20th, 2023
Anne Walsh is speaking at FDLI’s Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco IndustriesDecember 7th, 2022
Frank Sasinowski is speaking at the Milken Institute Partnering for Patients Forum 2022December 6th, 2022
Sara Koblitz is speaking at GRx+Bioxims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Kurt Karst is speaking at GRx+Biosims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Anne Walsh is speaking at International Bar Association Annual ConferenceNovember 3rd, 2022
Sara Koblitz is speaking at Food and Drug Law Journal 2022 Symposium – “The Interconnected Regulatory Landscape: Exploring FDA’s Relationship with Other Domestic Regulators”November 3rd, 2022
Sara Koblitz is speaking at ACI’s Virtual Series: Hatch-Waxman and BPCIA Passport to Proficiency Series: Focus on Bioequivalence, Exclusivity, Extensions, and Exceptions;October 25th, 2022